Literature DB >> 24925132

Laboratory preparation of Varicella-Zoster Virus: concentration of virus-containing supernatant, use of a debris fraction and magnetofection for consistent cell-free VZV infections.

Anna Sloutskin1, Ronald S Goldstein2.   

Abstract

The research laboratory generation of free Varicella-Zoster Virus (VZV) from cultured yields results relatively low titers, with the result that most study of VZV infection utilizes cell-associated infection. However, important aspects of VZV-cell interaction, such as the entry mechanism and superinfection exclusion have not yet been studied in detail, in part due to the difficulty in obtaining a high titer cell free virus. Here, a method to generate relatively high-titer cell-free VZV, based on a combination of previously published techniques and subsequent concentration is described. VZV-infected cells are disrupted, sonicated and clarified by centrifugation. The cell-free virus in the supernatant is then concentrated to yield up to 10(5)PFU/ml. The cell debris pellet, which contains up to 10(6)PFU/ml can also be used for non cell-associated infection. Magnetic nanoparticles available commercially can be used to further enhance infection by cell-free-VZV. The tools described here hold promise for better understanding of important aspects of VZV-cell interactions such as entry and latency.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cell-free virus; Magnetic infection; Varicella-Zoster Virus

Mesh:

Year:  2014        PMID: 24925132     DOI: 10.1016/j.jviromet.2014.05.027

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  7 in total

1.  Bioinformatically-predicted varicella zoster virus small non-coding RNAs are expressed in lytically-infected epithelial cells and neurons.

Authors:  Linoy Golani-Zaidie; Tatiana Borodianskiy-Shteinberg; Punam Bisht; Biswajit Das; Paul R Kinchington; Ronald S Goldstein
Journal:  Virus Res       Date:  2019-10-12       Impact factor: 3.303

2.  Interferon Gamma Inhibits Varicella-Zoster Virus Replication in a Cell Line-Dependent Manner.

Authors:  Akhalesh K Shakya; Seong K Kim; Dennis J O'Callaghan
Journal:  J Virol       Date:  2019-05-29       Impact factor: 5.103

3.  Studies of Infection and Experimental Reactivation by Recombinant VZV with Mutations in Virally-Encoded Small Non-Coding RNA.

Authors:  Punam Bisht; Biswajit Das; Tatiana Borodianskiy-Shteinberg; Paul R Kinchington; Ronald S Goldstein
Journal:  Viruses       Date:  2022-05-10       Impact factor: 5.818

4.  Varicella-Zoster Virus Expresses Multiple Small Noncoding RNAs.

Authors:  Amos Markus; Linoy Golani; Nishant Kumar Ojha; Tatiana Borodiansky-Shteinberg; Paul R Kinchington; Ronald S Goldstein
Journal:  J Virol       Date:  2017-11-30       Impact factor: 5.103

5.  Direct transfer of viral and cellular proteins from varicella-zoster virus-infected non-neuronal cells to human axons.

Authors:  Sergei Grigoryan; Michael B Yee; Yair Glick; Doron Gerber; Eldad Kepten; Yuval Garini; In Hong Yang; Paul R Kinchington; Ronald S Goldstein
Journal:  PLoS One       Date:  2015-05-14       Impact factor: 3.240

6.  An in vitro model of latency and reactivation of varicella zoster virus in human stem cell-derived neurons.

Authors:  Amos Markus; Ilana Lebenthal-Loinger; In Hong Yang; Paul R Kinchington; Ronald S Goldstein
Journal:  PLoS Pathog       Date:  2015-06-04       Impact factor: 6.823

7.  Antiviral Targeting of Varicella Zoster Virus Replication and Neuronal Reactivation Using CRISPR/Cas9 Cleavage of the Duplicated Open Reading Frames 62/71.

Authors:  Betty W Wu; Michael B Yee; Ronald S Goldstein; Paul R Kinchington
Journal:  Viruses       Date:  2022-02-12       Impact factor: 5.818

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.